Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Simpson, MD, MCR
Department of Dermatology, Oregon Health and Science University
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
115 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Woden Dermatology Pty Ltd.
Phillip, Australian Capital Territory, Australia
- Skin & Cancer Foundation Australia
Darlinghurst, New South Wales, Australia
- St. George Dermatology and Skin Cancer Center
Kogarah, New South Wales, Australia
- Veracity Clinical Research
Woolloongabba, Queensland, Australia
- Skin & Cancer Foundation Inc.
Carlton, Victoria, Australia
- Sinclair Dermatology
East Melbourne, Victoria, Australia
- Burswood Dermatology
Victoria Park, Western Australia, Australia
- Dr. Chih-Ho Hong Medical
Surrey, British Columbia, Canada
- Enverus Medical Research
Surrey, British Columbia, Canada
- Pacific Derm
Vancouver, British Columbia, Canada
- Winnipeg Clinic
Winnipeg, Manitoba, Canada
- Wiseman Dermatology Research
Winnipeg, Manitoba, Canada
- Brunswick Dermatology Centre
Fredericton, New Brunswick, Canada
- Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
- Eastern Canada Cutaneous Research
Halifax, Nova Scotia, Canada
- Kingsway Clinical Research
Etobicoke, Ontario, Canada
- Guenther Derm Research Centre
London, Ontario, Canada
- Lynderm Research Inc.
Markham, Ontario, Canada
- Dermedge Research
Mississauga, Ontario, Canada
- Dermatology & Cosmetic Surgery
North Bay, Ontario, Canada
- Derm Clinic of Dr. Robern
Ottawa, Ontario, Canada
- Skin Centre for Dermatology
Peterborough, Ontario, Canada
- Dermatology & Cosmetic Surgery
Richmond Hill, Ontario, Canada
- K. Papp
Waterloo, Ontario, Canada
- Xlr8 Medical Research
Windsor, Ontario, Canada
- Dr. David Gratton Dermatologue
Montreal, Quebec, Canada
- Crdq
Québec, Quebec, Canada
- Aarhus University Hospital
Aarhus, Denmark
- Bispebjerg Hospital
Hellerup, Denmark
- Gentofte Hospital
Hellerup, Denmark
- Spedali Civili Brescia
Brescia, Italy
- Policlinico-Vittorio Emanuele
Catania, Italy
- Opedale San Salvatore
L’Aquila, Italy
- Aou Pisa
Pisa, Italy
- Irccs San Gallicano
Rome, Italy
- Policlinico "agostino Gemelli"
Rome, Italy
- Istituto Clinico Humanitas
Rozzano, Italy
- Centrum Medyczne Gdynia
Gdynia, Poland
- Synexus Polska Gdyni
Gdynia, Poland
- Synexus Polska Katowicach
Katowice, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2017
- Primary completion
- 4 Sept 2018
- Completion
- 14 Aug 2019
- Last update posted
- 11 Mar 2025
- Registered enrollment
- 794
- Registry id
- NCT03160885
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.